Category: NxStage Medical Inc.Syndicate content

NxStage gains on Q4, 2014 beats, opens Boston dialysis centers

February 26, 2015 by Brad Perriello

NxStage Medical beats expectations with its 4th-quarter and full-year results and opens 2 new dialysis centers in the Boston area, sending share prices up today.

NxStage gains on Q4, 2014 beats, opens Boston dialysis centers

ExThera joins DARPA sepsis project

January 12, 2015 by Mark Hollmer

ExThera Medical joins NxStage Medical and Battelle on a project with the Pentagon's DARPA arm to develop a medical device to treat sepsis.

ExThera joins DARPA sepsis project

ExThera Medical signed on to a multi-company U.S. Defense Dept. contract focused on developing a medical device to treat sepsis. The California company's main contribution: A 2nd-generation version of its Seraph blood-filtering tech.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NxStage Medical wins FDA nod for nocturnal home dialysis

December 22, 2014 by Brad Perriello

NxStage Medical says it won 510(k) clearance from the FDA for nocturnal home hemodialysis treatments using its System One device.

NxStage Medical wins FDA nod for nocturnal homedialysis

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves

December 19, 2014 by Brad Perriello

Pulmonx taps former Asthmatx CEO Glen French to be its new chief executive.

Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves

Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NxStage study highlights advantages of home hemodialysis

November 13, 2014 by Val Kennedy

Home hemodialysis device maker NxStage Medical touts a new study showing that kidney patients who underwent frequent home hemodialysis had a better quality of life and lower risk of death than those who underwent peritoneal dialysis.

NxStage study highlights advantages of home hemodialysis

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Press Release: NxStage announces FDA clearance of Single Needle Technology

September 18, 2014 by MassDevice

Innovative needle design to enhance patient safety.

Press Release: NxStage announces FDA clearance of Single Needle Technology

LAWRENCE, Mass. -- 

NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite, has received FDA clearance.